Cargando…

Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders

The atypical antipsychotic quetiapine fumarate is available both as an immediate release (IR) and as an extended release (XR) formulation allowing flexibility of dosing for individual patients. Approved uses of quetiapine XR include the treatment of schizophrenia (including maintenance therapy for p...

Descripción completa

Detalles Bibliográficos
Autor principal:	El-Khalili, Nizar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496410/ https://www.ncbi.nlm.nih.gov/pubmed/23152684 http://dx.doi.org/10.2147/NDT.S14369

Ejemplares similares

The management of schizophrenia: focus on extended-release quetiapine fumarate
por: Peuskens, Joseph
Publicado: (2011)

Role of extended release quetiapine in the management of bipolar disorders
por: Al Jurdi, Rayan K, et al.
Publicado: (2010)

A randomized, double-blind study of the efficacy and tolerability of extended-release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder
por: Wang, Gang, et al.
Publicado: (2014)

Effects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorder
por: Endicott, Jean, et al.
Publicado: (2012)

Differential use of extended and immediate release quetiapine: a retrospective registry study of Finnish inpatients with schizophrenia spectrum and bipolar disorders
por: Hallinen, Taru, et al.
Publicado: (2012)

Pharmacotherapy of Bipolar Disorder with Quetiapine: A Recent Literature Review and an Update
por: Muneer, Ather
Publicado: (2015)

Pharmacokinetic evaluation of quetiapine fumarate controlled release hybrid hydrogel: a healthier treatment of schizophrenia
por: Akhlaq, Muhammad, et al.
Publicado: (2018)

Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies
por: Gajwani, Prashant, et al.
Publicado: (2007)

Update on schizophrenia and bipolar disorder: focus on cariprazine
por: Roberts, Rona Jeannie, et al.
Publicado: (2016)

Quetiapine extended‐release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis
por: Kishi, Taro, et al.
Publicado: (2019)

Comparison of D(2) dopamine receptor occupancy after oral administration of quetiapine fumarate immediate-release and extended-release formulations in healthy subjects
por: Nord, Magdalena, et al.
Publicado: (2011)

Results from a drug utilization study of extended release quetiapine fumarate prescribed by psychiatrists as treatment for major depressive disorder in selected countries in the European Union
por: Brody, Robert S., et al.
Publicado: (2018)

Quetiapine in the treatment of schizophrenia and related disorders
por: Riedel, Michael, et al.
Publicado: (2007)

Quetiapine N-oxide–fumaric acid (2/1)
por: Shen, Jin, et al.
Publicado: (2012)

Branch retinal vein occlusion associated with quetiapine fumarate
por: Yong, Ku Chui, et al.
Publicado: (2011)

Effect of Polymers and Permeation Enhancers in the Release of Quetiapine Fumarate Transdermal Patch through the Dialysis Membrane
por: Bhupathyraaj, Mullaicharam, et al.
Publicado: (2022)

Quetiapine monotherapy for bipolar depression
por: Thase, Michael E
Publicado: (2008)

The role of paliperidone extended release for the treatment of bipolar disorder
por: Marino, Jehan, et al.
Publicado: (2012)

Multi-center, randomized, double-blind, placebo-controlled study of quetiapine extended-release formulation in Japanese patients with bipolar depression
por: Murasaki, Mitsukuni, et al.
Publicado: (2018)

Early Symptom Improvement as a Predictor of Response to Extended Release Quetiapine in Major Depressive Disorder
por: McIntyre, Roger S., et al.
Publicado: (2015)

Formulation Design and Optimization of Orodispersible Tablets of Quetiapine Fumarate by Sublimation Method
por: Kalyankar, P., et al.
Publicado: (2015)

Carbamazepine extended-release capsules in bipolar disorder
por: Weisler, Richard H
Publicado: (2006)

Lurasidone, olanzapine, and quetiapine extended‐release for bipolar depression: A systematic review and network meta‐analysis of phase 3 trials in Japan
por: Kishi, Taro, et al.
Publicado: (2020)

Real-World Economic Outcomes of Brexpiprazole and Extended-Release Quetiapine Adjunctive Use in Major Depressive Disorder
por: Seetasith, Arpamas, et al.
Publicado: (2019)

Quetiapine fumarate augmentation for patients with a primary anxiety disorder or a mood disorder: a pilot study
por: Chen, Yi-Chih, et al.
Publicado: (2012)

The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder
por: Mundo, Emanuela, et al.
Publicado: (2006)

Rhabdomyolysis following Acute Extended-Release Quetiapine Poisoning: A Case Report
por: Liolios, Antonios, et al.
Publicado: (2012)

Quality by Design Approach for Development and Characterisation of  Solid Lipid Nanoparticles of Quetiapine Fumarate
por: Agarwal, Shweta, et al.
Publicado: (2020)

Combination quetiapine therapy in the long-term treatment of patients with bipolar I disorder
por: Hardoy, MC, et al.
Publicado: (2005)

Maintenance treatment of adolescent bipolar disorder: open study of the effectiveness and tolerability of quetiapine
por: Duffy, Anne, et al.
Publicado: (2009)

Convulsive syncope related to a small dose of quetiapine in an adolescent with bipolar disorder
por: Lai, Jianbo, et al.
Publicado: (2017)

Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression
por: Kanba, Shigenobu, et al.
Publicado: (2019)

Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: A retrospective cohort study
por: Berger, Ariel, et al.
Publicado: (2012)

Preparation, Characterization and Evaluation of Quetiapine Fumarate Solid Lipid Nanoparticles to Improve the Oral Bioavailability
por: Narala, Arjun, et al.
Publicado: (2013)

Central Composite Optimization of Glycerosomes for the Enhanced Oral Bioavailability and Brain Delivery of Quetiapine Fumarate
por: Zaki, Randa Mohammed, et al.
Publicado: (2022)

The efficacy and safety of once-daily quetiapine extended release in patients with schizophrenia switched from other antipsychotics: an open-label study in Chinese population
por: Pan, Pei-Yin, et al.
Publicado: (2015)

Quetiapine as add-on treatment for bipolar I disorder: efficacy in preventing relapse of depressive episodes
por: Hardoy, Maria Carolina, et al.
Publicado: (2007)

Hospital stay in patients admitted for acute bipolar manic episodes prescribed quetiapine immediate or extended release: a retrospective non-interventional cohort study (HOME)
por: Karamustafalıoğlu, Oğuz, et al.
Publicado: (2014)

A retrospective study of clinical usage of quetiapine XR and quetiapine IR in outpatients with schizophrenia in Denmark
por: Emborg, Charlotte, et al.
Publicado: (2012)

Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression
por: Gedge, Laura, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_88utaj7o2rtgcptk3honp41qt3